Although NIPP is well-documented for its cytotoxic effects on breast cancer cells, including the induction of DNA damage, its potential role in triggering STING activation and reprogramming the immune landscape remains largely uninvestigated. This evidence concerns the gene STING1 and breast carcinoma.